Genezen Secures $18.5 Million in Growth Equity to Expand Viral Vector Development and Manufacturing Capabilities ...Middle East

PR Newswire - News
Genezen Secures $18.5 Million in Growth Equity to Expand Viral Vector Development and Manufacturing Capabilities
Financing led by Ampersand Capital Partners with significant support from Genezen's management team and advisors Proceeds from financing will enable expansion of Genezen's viral vector development and manufacturing capacity and capabilities Pipeline of multiple client programs are fueling...

Hence then, the article about genezen secures 18 5 million in growth equity to expand viral vector development and manufacturing capabilities was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Genezen Secures $18.5 Million in Growth Equity to Expand Viral Vector Development and Manufacturing Capabilities )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News